Letters
Generic controlled-release oxycodone
Philip A. Baer, Joel Bordman and Erica L. Weinberg
CMAJ October 01, 2013 185 (14) 1251-1252; DOI: https://doi.org/10.1503/cmaj.113-2134
Philip A. Baer
Chair, Section on Rheumatology, Ontario Medical Association, Toronto, Ont., and Member of Executive, Ontario Rheumatology Association, and Editor-in-Chief, Journal of the Canadian Rheumatology Association (Baer), Newmarket, Ont.; Medical Director, Complex Pain Program, First Steps Clinics, Toronto, Ont. (Bordman); and physician (Weinberg), Toronto, Ont.
MDCMJoel Bordman
Chair, Section on Rheumatology, Ontario Medical Association, Toronto, Ont., and Member of Executive, Ontario Rheumatology Association, and Editor-in-Chief, Journal of the Canadian Rheumatology Association (Baer), Newmarket, Ont.; Medical Director, Complex Pain Program, First Steps Clinics, Toronto, Ont. (Bordman); and physician (Weinberg), Toronto, Ont.
MDErica L. Weinberg
Chair, Section on Rheumatology, Ontario Medical Association, Toronto, Ont., and Member of Executive, Ontario Rheumatology Association, and Editor-in-Chief, Journal of the Canadian Rheumatology Association (Baer), Newmarket, Ont.; Medical Director, Complex Pain Program, First Steps Clinics, Toronto, Ont. (Bordman); and physician (Weinberg), Toronto, Ont.
MDIn this issue
Article tools
Generic controlled-release oxycodone
Philip A. Baer, Joel Bordman, Erica L. Weinberg
CMAJ Oct 2013, 185 (14) 1251-1252; DOI: 10.1503/cmaj.113-2134
Related Articles
- No related articles found.
Cited By...
- No citing articles found.